Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2015

View Archived Issues

ValiRx acquires TRAC gene expression and biomarker technology

AstraZeneca supports Canadian National Access Project for Cancer Testing

Dermira releases phase IIb results of DRM-04

G1 Therapeutics completes Series B financing

Chronos Therapeutics establishes research collaboration with Kings College London

Adimab and Sanofi establish bispecific antibody collaboration

OnCore Biopharma describes license deal with NeuroVive in Tekmira Pharmaceutical merger document

Mitsubishi Tanabe Pharma updates activities of third quarter of fiscal 2014

Scientists identify new mutations amenable for therapeutic targeting in iCCA patients

Astellas Pharma reviews development highlights of third quarter of fiscal 2014

Sanofi presents highlights of fourth quarter 2014

Alkermes reports topline data from phase I study of ALKS-8700

Sodium channel modulators disclosed by Vertex Pharmaceuticals

Cadila Pharmaceuticals divulges agents for inflammation

FDA grants orphan drug status to tisagenlecleucel-T, copanlisib and ibrutinib for lymphomas

Cancer treatments receive FDA orphan drug status

Regulus Therapeutics reports topline data from RG-101 trial in HCV

Casi Pharmaceuticals reviews regulatory pathway for ENMD-2076

Epizyme patents EZH2 inhibitors

University of Texas discloses new sigma-receptor ligands

Boehringer Ingelheim Pharma presents new AMPK activators

Six-week ACH-3102/sofosbuvir regimen achieves 100% SVR12 in phase II study

STADApharm to launch Ebola rapid test

Roche acquires Signature Diagnostics

GSK and Theravance start second phase III trial of inhaled triple combination in COPD

LeafBio files IND application for Ebola virus therapeutic ZMapp

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...